Status:
COMPLETED
Tumour Registry Lung Cancer (TLK)
Lead Sponsor:
iOMEDICO AG
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Overview of treatment reality in patients with bronchial carcinoma requiring systemic treatment and being treated by office-based oncologists in Germany.
Detailed Description
The TLK is a prospective, longitudinal, nation wide cohort study that collects data on the treatment reality of patients with NSCLC and SCLC. At inclusion, data in patient characteristics, comorbiditi...
Eligibility Criteria
Inclusion
- histologically confirmed Small Cell Lung Cancer (SCLC), Non Small Lung Cancer (NSCLC) or neuroendocrine tumors receiving therapy
- written informed consent
- start of neoadjuvant, adjuvant or first-line therapy no longer than 4 weeks before informed consent
Exclusion
- patients not receiving any systemic therapy
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT01192919
Start Date
January 1 2010
End Date
July 1 2016
Last Update
March 2 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.